Integrated Investment Consultants LLC Sells 45,986 Shares of Clarivate Plc (NYSE:CLVT)

Integrated Investment Consultants LLC lowered its holdings in Clarivate Plc (NYSE:CLVT) by 47.6% during the fourth quarter, Holdings Channel.com reports. The firm owned 50,670 shares of the company’s stock after selling 45,986 shares during the period. Integrated Investment Consultants LLC’s holdings in Clarivate were worth $257,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Cerity Partners LLC lifted its position in Clarivate by 82.5% during the 3rd quarter. Cerity Partners LLC now owns 202,204 shares of the company’s stock worth $1,436,000 after buying an additional 91,384 shares in the last quarter. Susquehanna Fundamental Investments LLC acquired a new stake in Clarivate in the 2nd quarter valued at about $2,251,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Clarivate by 112.9% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,040,426 shares of the company’s stock worth $7,387,000 after acquiring an additional 551,838 shares during the last quarter. Baupost Group LLC MA grew its stake in shares of Clarivate by 27.2% during the second quarter. Baupost Group LLC MA now owns 38,929,635 shares of the company’s stock valued at $221,510,000 after purchasing an additional 8,331,233 shares during the last quarter. Finally, Verition Fund Management LLC increased its holdings in shares of Clarivate by 707.5% in the third quarter. Verition Fund Management LLC now owns 157,540 shares of the company’s stock valued at $1,119,000 after purchasing an additional 138,031 shares in the last quarter. Institutional investors own 85.72% of the company’s stock.

Insider Activity at Clarivate

In other Clarivate news, Director Michael J. Angelakis bought 765,000 shares of the firm’s stock in a transaction on Friday, November 22nd. The stock was purchased at an average cost of $5.19 per share, with a total value of $3,970,350.00. Following the completion of the purchase, the director now owns 3,465,000 shares in the company, valued at approximately $17,983,350. The trade was a 28.33 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 23.14% of the company’s stock.

Clarivate Stock Up 0.1 %

NYSE:CLVT opened at $5.10 on Friday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.84. Clarivate Plc has a 12-month low of $4.25 and a 12-month high of $9.60. The stock’s fifty day simple moving average is $5.19 and its 200-day simple moving average is $5.98. The firm has a market capitalization of $3.62 billion, a P/E ratio of -2.56 and a beta of 1.14.

Clarivate (NYSE:CLVT) last issued its earnings results on Wednesday, November 6th. The company reported $0.19 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.19. The firm had revenue of $622.20 million for the quarter, compared to analysts’ expectations of $640.81 million. Clarivate had a positive return on equity of 9.69% and a negative net margin of 50.00%. The company’s revenue was down 3.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.18 earnings per share. Equities research analysts expect that Clarivate Plc will post 0.63 earnings per share for the current year.

Clarivate declared that its Board of Directors has initiated a stock buyback plan on Monday, December 16th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to repurchase up to 12.8% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board believes its shares are undervalued.

Analyst Ratings Changes

Several research analysts have issued reports on CLVT shares. Barclays reduced their price objective on Clarivate from $5.00 to $4.00 and set an “underweight” rating on the stock in a report on Thursday, November 7th. Royal Bank of Canada decreased their price target on Clarivate from $7.00 to $6.00 and set a “sector perform” rating on the stock in a report on Thursday, November 7th. Finally, William Blair cut Clarivate from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $7.10.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.